You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Kuano raises £1m to further develop AI drug discovery platform

London-headquartered artificial intelligence company Kuano has raised £1m in seed funding to accelerate the development of its platform, focused on transforming the discovery of therapeutics targeting enzyme inhibition.